# MASSACHUSETTS GENERAL HOSPITAL: Aspirins legacy on cancer and overall benefit: risk balance over a 15-year horizon

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | MASSACHUSETTS GENERAL HOSPITAL |
| Location | BOSTON, MA |
| Project | Aspirins legacy on cancer and overall benefit: risk balance over a 15-year horizon |
| Project number | 3U01CA301988-03S1 |
| Mechanism | U01 |
| Institute | National Cancer Institute |
| Award | $364,000 |
| Awarded | 2026-09-17 |
| Project period | 2024-09-26 to 2029-08-31 |
| UEI | FLJ7DQKLL226 |

## Why this score
- Award of $364,000.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11535359). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.